biote Corp.

BTMD

----

Current ValuationThe current P/E ratio is 6.93, within the reasonable range, cheaper than 58.37% of the time in the past 3 years, and the industry ranks 8/255, the industry Median -1.20.

6.93xP/E

Stock price$1.13Earnings per share$0.16

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

0295887116

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x20x40x60x80x100x

P/E ratio
Name/Symbol
NVOUSNovo Nordisk AS	9.33x	4.32%	$168.60B
SGIOYUSShionogi	8.86x	--	$14.93B
INVAUSInnoviva	4.24x	32.30%	$1.51B
APMDUSApnimed	4.19x	114.94%	$686.15M
CRMDUSCormedix	3.10x	75.74%	$576.01M
ORMPUSOramed Pharma	0.99x	198.00%	$172.21M
OGIUSOrganigram	1.96x	510.33%	$122.03M
SDEVUSStablecoin Development	0.10x	--	$50.11M
BTMDUSbiote Corp.	6.93x	127.70%	$40.60M
OWPCUSOne World Products, Inc.	0.00x	--	$17.80K

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.